基因测序机器制造商Illumina(ILMN)2月6日盘后股价大跌5.12%,引发市场广泛关注。
数据显示,Illumina当日公布2024年第四季度财报,实现营收11.04亿美元,前值为11.22亿美元,高于预期的11亿美元。然而,公司预测2025年年收入为42.8亿美元至44亿美元,中间值低于分析师平均预期的43.9亿美元,未能达到市场期望,成为股价大跌的主要推手。
另外,公司表示该预测未考虑中国商务部最近将其列入"不可靠实体"名单的影响。落入黑名单可能面临各种制裁。鉴于中国约占Illumina7%的销售额,这一措施无疑增加了公司在中国市场前景的不确定性,从而进一步打击市场信心,对股价造成拖累。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.